- Drug Pipelines
- April 2025
- 204 Pages
Global
From €2694EUR$3,000USD£2,294GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1347EUR$1,500USD£1,147GBP
- Drug Pipelines
- April 2025
- 400 Pages
Global
From €4489EUR$5,000USD£3,823GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2694EUR$3,000USD£2,294GBP
- Report
- December 2024
- 200 Pages
Global
From €3367EUR$3,750USD£2,867GBP
- Report
- December 2024
- 200 Pages
Global
From €3367EUR$3,750USD£2,867GBP
- Report
- December 2024
- 200 Pages
Global
From €3367EUR$3,750USD£2,867GBP
- Report
- August 2024
- 200 Pages
Global
From €3474EUR$3,869USD£2,958GBP
- Report
- August 2024
- 200 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- May 2025
- 190 Pages
Global
From €4485EUR$4,995USD£3,819GBP
- Report
- March 2025
- 240 Pages
Global
From €4485EUR$4,995USD£3,819GBP
- Report
- April 2025
- 59 Pages
Global
From €2649EUR$2,950USD£2,256GBP
- Report
- January 2025
- 48 Pages
Global
From €2244EUR$2,499USD£1,911GBP
- Report
- September 2024
- 115 Pages
Global
From €4040EUR$4,500USD£3,441GBP
- Report
- October 2024
- 134 Pages
North America
From €3053EUR$3,400USD£2,600GBP
€3591EUR$4,000USD£3,058GBP
- Report
- August 2024
- 125 Pages
Asia Pacific
From €3098EUR$3,450USD£2,638GBP
- Report
- April 2022
- 400 Pages
Global
€1571EUR$1,750USD£1,338GBP
- Report
- November 2022
- 418 Pages
Global
From €2350EUR$2,804USD£2,071GBP
- Report
- February 2022
- 131 Pages
Global
From €4309EUR$4,799USD£3,669GBP
- Report
- September 2023
- 120 Pages
Global
From €4309EUR$4,799USD£3,669GBP

The oligonucleotide market is a subset of the biotechnology industry that focuses on the production and sale of oligonucleotides, which are short strands of nucleic acids used in a variety of applications. Oligonucleotides are used in research, diagnostics, and therapeutics, and are essential components of many biotechnological processes. They are used in a variety of applications, including gene expression analysis, gene cloning, and gene sequencing.
The oligonucleotide market is expected to grow in the coming years due to increasing demand for biotechnological products and services. The market is driven by advances in technology, such as the development of new sequencing techniques, and the increasing use of oligonucleotides in drug discovery and development.
Some of the major companies in the oligonucleotide market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Qiagen. These companies are involved in the production and sale of oligonucleotides, as well as the development of new technologies and products. Show Less Read more